U.S. Digital Health Market (By Component: Software, Hardware, Services; By Technology: Telehealthcare, mHealth, Digital Health Systems, Health Analytics) - Regional Outlook and Forecast 2024 to 2033
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
3.1. Market Snapshot
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
5.1. COVID-19 Landscape: U.S. Digital Health Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
8.1. U.S. Digital Health Market Revenue and Volume, by Component, 2024-2033
8.1.1. Software
8.1.1.1. Market Revenue and Volume Forecast (2021-2033)
8.1.2. Hardware
8.1.2.1. Market Revenue and Volume Forecast (2021-2033)
8.1.3. Services
8.1.3.1. Market Revenue and Volume Forecast (2021-2033)
9.1. U.S. Digital Health Market Revenue and Volume, by Technology, 2024-2033
9.1.1. Telehealthcare
9.1.1.1. Market Revenue and Volume Forecast (2021-2033)
9.1.2. mHealth
9.1.2.1. Market Revenue and Volume Forecast (2021-2033)
9.1.3. Digital Health Systems
9.1.3.1. Market Revenue and Volume Forecast (2021-2033)
9.1.4. Health Analytics
9.1.4.1. Market Revenue and Volume Forecast (2021-2033)
10.1. U.S.
10.1.1. Market Revenue and Volume Forecast, by Component (2021-2033)
10.1.2. Market Revenue and Volume Forecast, by Technology (2021-2033)
11.1. BioTelemetry Inc
11.1.1. Company Overview
11.1.2. Product Offerings
11.1.3. Financial Performance
11.1.4. Recent Initiatives
11.2. eClinicalWorks
11.2.1. Company Overview
11.2.2. Product Offerings
11.2.3. Financial Performance
11.2.4. Recent Initiatives
11.3. Allscripts Healthcare Solutions Inc
11.3.1. Company Overview
11.3.2. Product Offerings
11.3.3. Financial Performance
11.3.4. Recent Initiatives
11.4. iHealth Lab Inc
11.4.1. Company Overview
11.4.2. Product Offerings
11.4.3. Financial Performance
11.4.4. Recent Initiatives
11.5. AT & T
11.5.1. Company Overview
11.5.2. Product Offerings
11.5.3. Financial Performance
11.5.4. Recent Initiatives
11.6. Honeywell International Inc
11.6.1. Company Overview
11.6.2. Product Offerings
11.6.3. Financial Performance
11.6.4. Recent Initiatives
11.7. Athenahealth Inc.
11.7.1. Company Overview
11.7.2. Product Offerings
11.7.3. Financial Performance
11.7.4. Recent Initiatives
11.8. Cisco Systems
11.8.1. Company Overview
11.8.2. Product Offerings
11.8.3. Financial Performance
11.8.4. Recent Initiatives
11.9. McKesson Corporation
11.9.1. Company Overview
11.9.2. Product Offerings
11.9.3. Financial Performance
11.9.4. Recent Initiatives
12.1. Primary Research
12.2. Secondary Research
12.3. Assumptions
13.1. About Us
13.2. Glossary of Terms
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client